Back
Speaker illustration

Doctor Anna Gvozdeva

National Medical Research Center for Cardiology, Moscow (Russian Federation)

Presentations

Angiotensin neprilysin inhibition in HFpEF and advanced left ventricular hypertrophy: the rationale, design, and preliminary results of a randomized open-label pilot study

Event: Heart Failure 2021

Topic: Pharmacotherapy

Session: ePoster session

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources